Fructose‐1,6‐Diphosphate Suppresses T‐Lymphocyte Proliferation, Promotes Apoptosis and Inhibits Interleukins‐1, 6, β‐Actin mRNAs, and Transcription Factors Expression
Authors:
- J. JenkinsJJJ. Jenkins
- T. SkeltonTST. Skelton
- E. MeydrechEME. Meydrech
- Angel K. MarkovAMAngel K. Markov
- 1 January 2004
- journal article
- Published by Taylor & Francis in Immunological Investigations
- Vol. 33 (4) , 407-421
Abstract
The overall objective of this study was to determine the role fructose 1,6-diphosphate (FDP), a naturally occurring glycolytic intermediate, plays in activated T-lymphocytes. The hypothesis is twofold. First, we propose that FDP inhibits T cell proliferation to a greater extent than fructose-1-phosphate (F1P), fructose-6-phosphate (F6P) and mannose-6-phosphate (M6P); second, we argue that FDP suppresses immune activation by inhibiting inflammatory cytokine expression, inhibiting expression of key transcription factors, and by inducing apoptosis in immune cells. Rat spleen cells were incubated with concanavalin A (ConA) and increasing concentrations of FDP. Proliferation was determined by tritiated thymidine uptake. FDP inhibited splenocyte proliferation in a dose-related manner while F1P, F6P, M6P demonstrated inhibition only at high concentrations (5000 microg/ml). RNA was harvested from FDP and ConA-treated cells and IL-1 and IL-6 gene expression was analyzed by RT-PCR. IL-1 and IL-6 mRNA expression was completely inhibited at 500-5000 microg/ml FDP. Apoptosis in FDP-treated lymphocytes was determined by DNA fragmentation and flow cytometry. Propidium iodide (PI) staining demonstrated a 39% rate of apoptosis in splenocytes treated with ConA and 5000 microg/ml FDP. Extensive DNA fragmentation was present at 250-5000 microg/ml FDP, and maximal inhibition occurred at 5 microg/ml. F1P, F6P and M6P showed maximal inhibition only at 5000 microg/ml. Nuclear extracts from FDP-treated splenocytes were analyzed by electrophoretic mobility shift assay. ConA activation of NF-kappaB and AP-1 was dramatically inhibited by FDP. Interestingly, beta-actin showed extensive inhibition with FDP and ConA, thus suggesting new possibilities of its being used as a therapeutic modality in arterial injury where the beta-actin, an important cytoskeleton element, plays a very important role. These data indicate that FDP may be a useful immunosuppressive agent. In conclusion, FDP is not only an immunosuppressant but also an anti-inflammatory agent.Keywords
This publication has 32 references indexed in Scilit:
- Cytokine response after percutaneous coronary intervention in stable angina: Effect of selective glycoprotein IIb/IIIa receptor antagonismAmerican Heart Journal, 2003
- Myosin remodelling in the contracting A7r5 smooth muscle cellActa Physiologica Scandinavica, 2003
- Fructose-1,6-diphosphate alone and in combination with cyclosporine potentiates rat cardiac allograft survival and inhibits lymphocyte proliferation and interleukin-2 expression1Transplantation, 2002
- PREVENTION OF ?-NAPHTHYLTHIOUREA-INDUCED PULMONARY EDEMA WITH FRUCTOSE-1,6-DIPHOSPHATEExperimental Lung Research, 2002
- Systemic interleukin‐1 α and interleukin‐2 secretion in response to acute stress and to corticotropin‐releasing hormone in humans*European Journal of Clinical Investigation, 1994
- CHRONIC VASCULAR REJECTION OF THE HEART AND THE KIDNEY—HAVE RATIONAL TREATMENT OPTIONS EMERGED?Transplantation, 1992
- Prevention of ischemic-hypoxic brain injury and death in rabbits with fructose-1,6-diphosphate.Stroke, 1990
- Hemodynamics and metabolic effects of fructose 1–6 diphosphate in ischemia and shock — experimental and clinical observationsAnnals of Emergency Medicine, 1986
- Hemodynamic and electrocardiographic effects of fructose-1,6-diphosphate in acute myocardial infarctionThe American Journal of Cardiology, 1985
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976